Solubilizing effect of the p-phosphonate calix[n]arenes towards poorly soluble drug molecules such as nifedipine, niclosamide and furosemide

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 74, Issue 1-4, 2012, Pages 415-423

  Bayrakcı, Mevlüt ^a,b   Ertul, Şeref ^b   Yılmaz, Mustafa ^b  

^a NIGDE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Calixarene; Drug; Furosemide; Niclosamide; Nifedipine

Indexed keywords

EID: 84864440406     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-012-0135-7     Document Type: Article

References (45)

1. Gutsche, C.D.: In: Stoddart, J.F. (ed.) Calixarenes Revisited in Monograph in Supramolecular Chemistry. The Royal Society of Chemistry, Cambridge (1998)
2. V Böhmer 1995 Calixarenes, macrocycles with (almost) unlimited possibilities Angew. Chem. Int. Ed. Engl 34 713 745 10.1002/anie.199507131
3. MA Tairov MO Vysotsky OI Kalchenko VV Pirozhenko VI Kalchenko 2002 Symmetrical and inherently chiral water-soluble calix[4]arenes bearing dihydroxyphosphoryl groups J. Chem. Soc. Perkin Trans. 1 1405 1411 10.1039/b110691k (Pubitemid 35187090)
4. Gokel, G.W.: Crown Ethers and Cryptands: Monographs in Supramolecular Chemistry. The Royal Society of Chemistry, Cambridge (1991)
5. Szetjli, J.: Cyclodextrin Technology. Kluwer Academic, Dordrecht (1988)
6. CD Gutsche B Dhawan JA Levine KH No LJ Bauer 1983 Calixarenes 9: conformational isomers of the ethers and esters of calix[4]arenes Tetrahedron 39 409 426 10.1016/S0040-4020(01)88541-0 1:CAS:528:DyaL3sXhvFOhtbY%3D
7. Z Asfari R Abidi F Arnaud-Neu J Vicens 1992 Synthesis and complexing properties of a double-calix[4]arene crown ether J. Inclusion Phenom. 13 163 169 10.1007/BF01053640 1:CAS:528:DyaK38XltVaqt7g%3D
8. Asfari, Z.; Bohmer, V.; Harrowfield, M.Mc.B.; Vicens, J.: Calixarenes 2001. Kluwer, Dordrecht (2001)
9. K Niikura E Anslyn 1999 Azacalixarene: synthesis, conformational analysis, and recognition behavior toward anions J. Chem. Soc. Perkin Trans. 2 2769 2775 (Pubitemid 129561071)
10. M Almi A Arduini A Casnati A Pochini R Ungaro 1989 Chloromethylation of calixarenes and synthesis of new water-soluble macrocyclic hosts Tetrahedron 45 2177 2182 10.1016/S0040-4020(01)80077-6 1:CAS:528:DyaK3cXntFSl
11. CD Gutsche I Alam 1988 Calixarenes.23. The complexation and catalytic properties of water-soluble calixarenes Tetrahedron 44 4689 4694 10.1016/S0040-4020(01)86171-8 1:CAS:528:DyaL1MXhsFertr0%3D
12. S Shinkai H Kawabata T Matsuda H Kawaguchi O Manage 1990 Synthesis and inclusion properties of neutral water-soluble calixarenes Bull. Chem. Soc. Jpn. 63 1272 1274 10.1246/bcsj.63.1272 1:CAS:528:DyaK3cXkvFOitLg%3D (Pubitemid 20314919)
13. A Marra M-C Scherrmann A Dondoni A Casnati P Minari R Ungaro 1994 Sugar calixarenes-preparation of calix[4]arenes substituted at the lower and upper rims with o-glycosyl groups Angew. Chem. Intl. Ed. Engl. 33 2479 2481 10.1002/anie.199424791 (Pubitemid 24977333)
14. Y Shi Z Zhang 1994 Host-guest interactions in aqueous media with p-tert-butylcalix[4]arene bearing polyoxyethylene chains J. Inclusion Phenom. Macrocycl. Chem. 18 137 147 10.1007/BF00705817 1:CAS:528:DyaK2MXjtVajtro%3D
15. H Ai SA Jones MM de Villiers YM Lvov 2003 Nano-encapsulation of furosemide microcrystals for controlled drug release J. Control Release 86 59 68 10.1016/S0168-3659(02)00322-X 1:CAS:528:DC%2BD38XpsFSjsrY%3D (Pubitemid 35461974)
16. B Devarakonda RA Hill W Liebenberg M Brits MM de Villiers 2005 Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins Int. J. Pharm. 304 193 209 10.1016/j.ijpharm.2005.07.023 1:CAS:528:DC%2BD2MXhtFSitLnP (Pubitemid 41427662)
17. KM Boje M Sak HL Fung 1998 Complexation of nifedipine with substituted phenolic ligands Pharm. Res. 5 655 659 10.1023/A:1015979021590
18. A Al-Omar S Abdou L De Robertis A Marsura C Finance 1999 Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrugresistant adenocarcinoma cell line Bioorg. Med. Chem. Lett. 9 1115 1120 10.1016/S0960-894X(99)00150-X 1:CAS:528:DyaK1MXjtVKls7o%3D (Pubitemid 29204668)
19. JJ Garcia-Rodriguez J Torrado F Bolas 2001 Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes Parasite 8 188 190
20. Frömming, K.H.; Szejtli, J.: Cyclodextrin in Pharmacy. Kluwer Academic, Dordrecht (1994)
21. Y Zhang RA Agbaria NE Mukundan IM Warner 1996 Spectroscopic studies of water-soluble sulfonated calix[6]arene J. Inclusion Phenom. Mol. Recognit. Chem. 24 353 365 10.1007/BF01041119
22. S Shinkai K Araki O Manabe 1988 Does the calixarene cavity recognize the size of guest molecules? On the hole-size selectivity in watersoluble calixarenes J. Chem. Soc. Chem. Commun. 3 187 189 10.1039/c39880000187
23. JM Shuette TT Ndou IM Warner 1992 Cyclodextrin-induced symmetry of achiral nitrogen heterocycles J. Phys. Chem. 96 5309 5314 10.1021/j100192a025
24. RV Rodik VI Boyko VI Kalchenko 2009 Calixarenes in bio-medical researches Curr. Med. Chem. 16 1630 1655 10.2174/092986709788186219 1:CAS:528: DC%2BD1MXmsFWgsbo%3D
25. P Shahgaldian E Da Silva AW Coleman 2003 A first approach to the study of calixarene solid lipid nanoparticle (SLN) toxicity J. Incl. Phenom. 46 175 177 10.1023/A:1026301906487 1:CAS:528:DC%2BD3sXosFCmsL8%3D (Pubitemid 39011188)
26. E Memişoglu A Bochot M Özalp M Şen D Duchene AA Hincal 2003 Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes Pharm. Res. 20 117 125 10.1023/A:1022263111961 (Pubitemid 36152926)
27. M Bayrakci S Ertul O Sahin M Yilmaz 2009 Synthesis of two new p-tert-butylcalix[4]arene b-ketoimin derivatives for extraction of dichromate anion J. Inclusion Phenom. Macrocycl. Chem. 63 241 247 10.1007/s10847-008-9513-6 1:CAS:528:DC%2BD1MXjsFKmsb4%3D
28. Ş Ertul M BayrakcI M Yilmaz 2010 Removal of chromate and phosphate anion from aqueous solutions using calix[4]arene receptors containing proton switchable units J. Hazard. Mater. 181 1059 1065 10.1016/j.jhazmat.2010.05.121 1:CAS:528:DC%2BC3cXosF2gs74%3D
29. M Bayrakci S Ertul M Yilmaz 2009 Synthesis of di-substituted calix[4]arene-based receptors for extraction of chromate and arsenate anions Tetrahedron 65 7963 7968 10.1016/j.tet.2009.07.062 1:CAS:528:DC%2BD1MXhtVSlsL3E
30. W Yang MM de Villiers 2004 The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[n]arenes E. J. Pharm. Biopharm 58 629 636 10.1016/j.ejpb.2004.04.010 1:CAS:528:DC%2BD2cXnvFagur0%3D (Pubitemid 39297110)
31. W Yang MM de Villiers 2005 Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic AAPS J. 7 241 248 10.1208/aapsj070123 (Pubitemid 41554284)
32. W Yang MM de Villiers 2004 Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes J. Pharm. Pharmacol. 56 703 708 10.1211/0022357023439 1:CAS:528:DC%2BD2cXmtFSks7o%3D (Pubitemid 38801685)
33. BayrakcI, M.; Ertul, S.; Yilmaz, M.: Transportation of poorly soluble drug molecules from the organic phase to the aqueous phase by using phosphorylated calixarenes. J. Chem. Eng. Data. doi: 10.1021/je2004319
34. N Özdemir S Ordu 1998 Improvement of dissolution properties of furosemide by complexation with β-cyclodextrin Drug Dev. Ind. Pharm. 24 19 25 10.3109/03639049809082348 (Pubitemid 28080834)
35. HO Ammar M Ghorab SA El-Nahhas LH Emara TS Makram 1999 Inclusion complexation of furosemide in cyclodextrins Die Pharm. 54 142 144 1:CAS:528:DyaK1MXhsVyjtb8%3D
36. GG Talanova VS Talanov MG Gorbunova H-S Hwang RA Bartsch 2002 Effect of upper rim para-alkyl substituents on extraction of alkali and alkaline earth metal cations by di-ionizable calix[4]arenes J. Chem. Soc. Perkin Trans. 2 2072 2077
37. H Zhou D Liu J Gega K Surowiec DW Purkiss RA Bartsch 2007 Effect of para-substituents on alkaline earth metal ion extraction by proton di-ionizable calix[4]arene-crown-6 ligands in cone, partial-cone and 1,3-alternate conformations Org. Biomol. Chem. 5 324 332 10.1039/b611570e 1:CAS:528: DC%2BD2sXhtlShtA%3D%3D (Pubitemid 46058482)
38. Higuchi, T.; Connors, K.A.: Phase-solubility techniques. In: Reilley, C.N. (ed.) Advances in analytical chemistry and instrumentation. Wiley, New York (1965)
39. R Arun CK Ashok Kumar VVNSS Sravanthi 2008 Cyclodextrins as drug carrier molecule: a review Sci. Pharm. 76 567 598 10.3797/scipharm.0808-05
40. A Farcas N Jarroux A-M Farcas V Harabagiu P Guegan 2006 Synthesis and characterization of furosemide complex in β-cyclodextrin Digest J. Nano. Biostructure 1 55 60
41. RM Amin Kreaz GY Dombi M Kata 1998 The influence of β-cyclodextrins on the solubility of furosemide J. Inclusion Phenom. Mol. Recognit. Chem. 31 189 196 10.1023/A:1007909715459
42. Ali, S.L.: In: Florey, K. (ed.) Nifedipine, Analytical Profiles of Drug Substances. Academic Press, New York (1989)
43. + -selective receptors J. Phys. Org. Chem. 14 468 473 10.1002/poc.382 1:CAS:528:DC%2BD3MXlsVCrsrw%3D (Pubitemid 32651540)
44. V Nikolić D Ilić L Nikolić M Stanković M Cakić L Stanojević A Kapor M Popsavin 2010 The protection of nifedipin from photodegradation due to complex formation with β-cyclodextrin Central Eur. J. Chem. 8 744 749 10.2478/s11532-010-0043-x
45. Reynolds, J.E.F.: In: Martindale (ed.) The Extra Pharmacopoeia, 29th ed. The pharmaceutical press, London (1989)